Cite

HARVARD Citation

    Gardner, S. et al. (2022). Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology advances. 4 (1), p. . [Online]. 
  
Back to record